APA (7th ed.) Citation

Cosgrove,David, Tan,Ruoding, Osterland,Andrew, Hernandez,Sairy, Ogale,Sarika, Mahrus,Sami, . . . Singal,Amit. (2025). Atezolizumab Plus Bevacizumab in Patients with Unresectable Hepatocellular Carcinoma: Real-World Experience From a US Community Oncology Network. Journal of Hepatocellular Carcinoma, Volume 12, 791.

Chicago Style (17th ed.) Citation

Cosgrove,David, et al. "Atezolizumab Plus Bevacizumab in Patients with Unresectable Hepatocellular Carcinoma: Real-World Experience From a US Community Oncology Network." Journal of Hepatocellular Carcinoma Volume 12 (2025): 791.

MLA (9th ed.) Citation

Cosgrove,David, et al. "Atezolizumab Plus Bevacizumab in Patients with Unresectable Hepatocellular Carcinoma: Real-World Experience From a US Community Oncology Network." Journal of Hepatocellular Carcinoma, vol. Volume 12, 2025, p. 791.